Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

BD and Fujirebio sign biomarker assay agreement to improve cancer detection

May 6, 2009

Epigenomics and Predictive Biosciences sign prostate cancer biomarker deal

April 29, 2009

Synairgen reports preliminary findings from phase I trial of IFN-beta biomarker neopterin

April 6, 2009

BioPorto Diagnostics launches ELISA kit for measuring APC-PCI biomarker

March 20, 2009

NIH awards phase I grant to Oligomerix for biomarker assays in AD

Feb. 27, 2009

Epigenomics and Quest sign nonexclusive licensing agreement for mGSTP1 DNA biomarker

Feb. 27, 2009

Compugen announces discovery of ovarian cancer biomarker CGEN-327

Feb. 4, 2009

Neogenix to initiate clinical trial of monoclonal antibodies for colorectal and pancreatic cancer

Dec. 15, 2008

Epigenomics presents update on PRESEPT clinical study of Septin 9 biomarker in colorectal cancer

Oct. 28, 2008

Epigenomics reports positive results from prognostic prostate cancer study

Oct. 20, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...